|
COMMERCE BUSINESS DAILY ISSUE OF JULY 29,1999 PSA#2398National Institutes of Health, Division of Research Contracts,
OCM/OA/OD, 6100 Executive Blvd., MSC 7540, Room 6E01, Bethesda,
Maryland 20892-7540 A -- PATHOLOGY MONITORING OF NIA AGED RODENT COLONIES SOL NIH-AG-99-11
DUE 091099 POC JONATHAN FERGUSON, Contracting Officer, (301) 496-4487
E-MAIL: Click here to contact the Contracting Officer via,
JF27T@NIH.GOV. This is a synopsis/solicitation for commercial items
prepared in accordance with the format in FAR subpart 12.6, as
supplemented with additional information included in this notice. This
announcement constitutes the only solicitation and proposals are
hereby being requested. Solicitation NIH-AG-99-11 is a Request for
Proposal. The duration of the proposed firm-fixed-price contract is one
year with four (04) successive one year option periods. The
solicitation document and incorporated provisions and clauses are those
in effect through Federal Acquisition Circular 97-12. The Standard
Industrial Classification code is 8731 and the business size is 500
employees. This is a small business set aside. SECTION C: The objective
of this project is to provide an independent surveillance of the health
status of mice and rats in NIA supported, contractor maintained
colonies. The Project Officer will select animals to be shipped from
the National Institute on Aging (NIA) colonies to an independent
laboratory for health and pathology evaluation from the inventory
maintained in the NIA Resource Development Office which effectively
samples the range of ages and holding rooms that characterize the
colonies. Specifically, the Contractor shall perform clinical
evaluation of mice and rats selected by the Project Officer from the
NIA colonies and shipped (at no cost to the contractor) on a quarterly
basis. Total number of mice anticipated on an annual basis are 125,
125, 125, 125 and 175 for years 1 through 5 respectively and the total
number of rats anticipated annually are 125, 125, 175, 175 and 225
years 1 through 5 respectively. Animals will be identified as to which
barrier and room they were housed. In the event of an apparent
outbreak of disease, or serious question regarding the health status of
a group of animals, the contractor shall immediately contact the
Project Officer by telephone and follow-up with written notification.
This schedule may be altered after consultation between the Project
Officer, the ContractingOfficer, the Colony Contractor, and the
Monitoring Contractor (this contract) in such an event. Upon receipt of
animals from the Colony Contractor, the Monitoring Contractor shall
divide each quarterly shipment of animals from each colony contract
into two (2) groups, the one group consisting of 80% of the animals
will be evaluated with the basic profile (described below). The other
group consisting of 20% of the animals will be evaluated for the agents
listed under Basic profile plus those agents listed under comprehensive
profile (described below). All tests are applied to both rats and mice
unless indicated specific to either rats (R) or mice (M).
Specifically, the contractor shall: (i) Describe general conditions of
all animals, weight, and any visible lesions or symptomatology; and
(ii) Conduct a gross pathology on all animals using procedures that
will maximize the chance for detection of the agents listed below. 1)
Gross pathologic observations of all animals. 2.(a) Agents for Basic
Profile (80% of animals) -- SEROLOGY: MHV (M), Ectromelia virus (M),
Mouse paroviruses (M), Theiler's (M), LCMV (M), Rotavirus (M), Rat
paroviruses (R), Rat coronaviruses (R), PVM, Sendai; MICROBIOLOGY:
Mycoplasma pulmonis, Corynebacterium kutscheri, Strep. pneumoniae,
Citrobacter freundii (4280), Pseudomonas sp., Salmonella enteritidis;
PARASITOLOGY: Spironucleus muris, Giardia sp., Cryptosporidium sp.,
Syphacia sp., Hymenolepis sp., Mites; HISTOPATHOLOGY: GI tract (Small
intestine, Cecum, Colon), Respiratory Tract (Nasal passages, Middle
ear, Lungs, Trachea), Liver. 2.(b) Agents for Comprehensive Profile
(20% of animals) -- SEROLOGY: Polyomavirus (M), LDV (M),TMEV (R),
Hantaviruses (R), Reoviruses, Adenoviruses; MICROBIOLOGY: CAR bacillus
(histopathology), Pasteurella pneumonotropica, Bacillus piliformis
(histopathology); HISTOPATHOLOGY: Spleen, Thymus, Heart, Kidney,
Reproductive organs (Ovaries, Uterus, Testes, Prepuce), Brain, Skin,
Salivary Gland (R), Harderian Gland (R). SECTION D: All deliverables
required under this contract shall be packaged, marked and shipped in
accordance with Government specifications. The Contractor shall
guarantee that all required materials shall be delivered in immediate
usable and acceptable condition. SECTION E: INSPECTION AND ACCEPTANCE
-- The deliverables shall be inspected and accepted at destination by
the NIH Project Officer. SECTION F: Required Reports/Deliverables --
One copy of the reports below shall be submitted to the Project
Officer, and one copy of items (b) and (c) shall be submitted to the
Contracting Officer. (a) The data expected to be generated from these
evaluations will be gross pathology, histopathology, and virology data
on each individual animal submitted for evaluation. Data shall be
collected on forms supplied by the Contractor in a format approved by
the Project Officer. Copies of raw data forms for each animal, together
with a summary report of findings shall be delivered to the Project
Officer within 30 calendar days from the date the animals are submitted
for evaluation. The Contractor will be expected to retain at least one
copy of each raw data form for use in preparation of an annual report.
(b) The original annual report shall be delivered to the Project
Officer and one copy of the annual report shall be delivered to the
Contracting Officer within 90 calendar days of the completion of each
project year. This report shall consist of a summary of the number,
strain and sex of the animals evaluated, a tabulation of the results of
the evaluations, and a Contractor's statement regarding the
significance of these results in terms of the success of colony
management practices and the health of colony animals. (c) The original
final report shall be delivered to the Project Officer and one copy of
the final report shall be delivered to the Contracting Officer. The
final report shall consist of the work performed and results obtained
for the entire contract period of performance. The final report is due
upon completion of the contract. (d) The Contractor shall submit a
summary (not to exceed 200 words) of salient results achieved during
the performance of the contract. The report of salient results is due
upon completion of the contract. The following clauses are incorporated
into the solicitation: FAR 52.212-1 INSTRUCTIONS TO OFFERORS-COMMERCIAL
ITEMS; FAR 52.212-2 EVALUATION-COMMERCIAL ITEMS. The Government shall
award a contract resulting from this solicitation to the responsible
offeror whose offer conforming to this solicitation will be most
advantageous to the Government, price and other factors considered. The
following factors, listed in order of relative importance, shall be
used to evaluate offers: 1. Experience: (60 points) (a) Documented
evidence of experience in pathological, microbiological and serological
assessment of health status of mice and rats, with specific experience
in tests required in this workscope. (b) A demonstrated knowledge of
what tests should be performed on what specific tissues in order to
apprize the Project Officer of the current level of colony health. (c)
Evidence of knowledge specific to pathological assessment and health
status of aged mice and rats. Specific evidence (e.g. publication,
training, prior experience) specific to aged rodents should be
provided; 2. Facilities: (20 points) Suitability of facilities for
short-term maintenance of animals to be evaluated prior to evaluation.
Must detail effective system to protect these animals from
contamination by other animals passing through facility. Must
demonstrate competence in laboratory quality control through such
measures as: copies of lab protocols, quality control procedures, lists
of reference reagents, and history of reliability; 3. Awareness: (20
points) A demonstrated awareness of diseases, degenerative problems,
and other conditions likely to be observed in the conduct of this
project and the significance of these observations to the general
health status of the colonies being monitored; and 4. Price: Price is
to be proposed on a cost per animal basis. The technical proposal shall
receive paramount consideration in making an award under this
solicitation.; Offeror must include a completed copy of FAR 52.212-3
OFFEROR REPRESENTATIONS AND CERTIFICATIONS-COMMERCIAL ITEMS with its
offer; FAR 52.212-4 CONTRACT TERMS AND CONDITIONS-COMMERCIAL ITEMS; FAR
52.212-5 CONTRACT TERMS AND CONDITIONS REQUIRED TO IMPLEMENT STATUTES
OR EXECUTIVE ORDERS-COMMERCIAL ITEMS, applies to this acquisition with
following additional clauses: 52.203-6 RESTRICTIONS ON SUBCONTRACTOR
SALES TO THE GOVERNMENT with ALTERNATE I, 52.203-10 PRICE OR FEE
ADJUSTMENT FOR ILLEGAL OR IMPROPER ACTIVITY, 52.219-8 UTILIZATION OF
SMALL, SMALL DISADVANTAGED AND WOMEN-OWNED SMALL BUSINESS CONCERNS,
52.219-14 LIMITATION ON SUBCONTRACTING, 52.222-26 EQUAL OPPORTUNITY,
52.222-35 AFFIRMATIVE ACTION FOR SPECIAL DISABLED AND VIETNAM ERA
VETERANS, 52.222-36 AFFIRMATIVE ACTION FOR HANDICAPPED WORKERS,
52.222-37 EMPLOYMENT REPORTS ON SPECIAL DISABLED VETERANS AND VETERANS
OF THE VIETNAM ERA, and 52.225-3 BUY AMERICAN ACT. The following
additional clauses apply to this acquisition: FAR 52.215-41
REQUIREMENTS FOR COST OR PRICING DATA OR INFORMATION OTHER THAN COST OR
PRICING DATA, 52.215-43 AUDIT-COMMERCIAL ITEMS, 52.217-5 EVALUATION OF
OPTIONS, and PHS 352.280-2 CARE OF LIVE VERTEBRATE ANIMALS. Direct all
questions or inquiries referencing RFP No. NIH-AG-99-11, by fax (301)
402-0178 or phone (301) 496-4487 to Mr. Jonathan Ferguson. Submit in
writing, an original and eight (08) copies of the technical proposal
and an original and four (04) business proposals no later than 4:00
p.m. local time, September 10, 1999. Please reference the solicitation
number on proposals. If using U.S. Postal Service, send proposals to:
National Institutes of Health, Division of Research Contracts, OCM,
6100 Executive Blvd., Room 6E01, MSC 7540, Bethesda, MD 20892-7540. If
using delivery service or hand-delivering, send proposals to: National
Institutes of Health, Division of Research Contracts, OCM, 6100
Executive Blvd., Room 6E01, Rockville, MD 20852. Posted 07/27/99
(W-SN359326). (0208) Loren Data Corp. http://www.ld.com (SYN# 0009 19990729\A-0009.SOL)
A - Research and Development Index Page
|
|